Kabra Drugs informs about standalone financial results

15 Feb 2017

Kabra Drugs has informed about Standalone Financial Results, Limited Review for the period ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Related Kabra Drugs Ltd. Links:

Kabra Drugs Share Price

3.38 0.00 (0.00%) Nov 17, 18:55
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 519.90
Dr. Reddys Lab 4910.95
Lupin 895.20
Piramal Enterprises 1423.95
Cadila Healthcare 429.10
View more..
Sensex vs Kabra Drugs
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback